CN106317263A - 一种医用光固化水凝胶中可见光引发体系及其光固化方法 - Google Patents
一种医用光固化水凝胶中可见光引发体系及其光固化方法 Download PDFInfo
- Publication number
- CN106317263A CN106317263A CN201610705826.7A CN201610705826A CN106317263A CN 106317263 A CN106317263 A CN 106317263A CN 201610705826 A CN201610705826 A CN 201610705826A CN 106317263 A CN106317263 A CN 106317263A
- Authority
- CN
- China
- Prior art keywords
- hydrogel
- visible light
- medical
- component
- initiation system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 95
- 238000000016 photochemical curing Methods 0.000 title claims abstract description 65
- 230000000977 initiatory effect Effects 0.000 title claims abstract description 63
- 238000000034 method Methods 0.000 title claims abstract description 22
- 239000002243 precursor Substances 0.000 claims abstract description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000003504 photosensitizing agent Substances 0.000 claims abstract description 18
- 239000000843 powder Substances 0.000 claims abstract description 18
- 108010013296 Sericins Proteins 0.000 claims abstract description 13
- 239000007788 liquid Substances 0.000 claims description 32
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 11
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 9
- 239000002202 Polyethylene glycol Substances 0.000 claims description 9
- 229920001223 polyethylene glycol Polymers 0.000 claims description 9
- 235000019192 riboflavin Nutrition 0.000 claims description 9
- 229960002477 riboflavin Drugs 0.000 claims description 9
- 239000002151 riboflavin Substances 0.000 claims description 9
- -1 methacrylic acid glycol ester Chemical class 0.000 claims description 8
- 229920000642 polymer Polymers 0.000 claims description 8
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 8
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 6
- 239000000178 monomer Substances 0.000 claims description 5
- 241000233803 Nypa Species 0.000 claims description 4
- 235000005305 Nypa fruticans Nutrition 0.000 claims description 4
- 229930006711 bornane-2,3-dione Natural products 0.000 claims description 4
- 238000005352 clarification Methods 0.000 claims description 4
- 125000004386 diacrylate group Chemical group 0.000 claims description 4
- SEACYXSIPDVVMV-UHFFFAOYSA-L eosin Y Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 SEACYXSIPDVVMV-UHFFFAOYSA-L 0.000 claims description 4
- 150000002496 iodine Chemical class 0.000 claims description 4
- QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 claims description 4
- 229920005615 natural polymer Polymers 0.000 claims description 4
- VNQXSTWCDUXYEZ-UHFFFAOYSA-N 1,7,7-trimethylbicyclo[2.2.1]heptane-2,3-dione Chemical compound C1CC2(C)C(=O)C(=O)C1C2(C)C VNQXSTWCDUXYEZ-UHFFFAOYSA-N 0.000 claims description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 3
- 229920002101 Chitin Polymers 0.000 claims description 3
- 229920001661 Chitosan Polymers 0.000 claims description 3
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- 239000004305 biphenyl Substances 0.000 claims description 3
- 235000010290 biphenyl Nutrition 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- 239000002105 nanoparticle Substances 0.000 claims description 3
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 3
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 3
- 239000004626 polylactic acid Substances 0.000 claims description 3
- 229930187593 rose bengal Natural products 0.000 claims description 3
- AZJPTIGZZTZIDR-UHFFFAOYSA-L rose bengal Chemical compound [K+].[K+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 AZJPTIGZZTZIDR-UHFFFAOYSA-L 0.000 claims description 3
- 229940081623 rose bengal Drugs 0.000 claims description 3
- STRXNPAVPKGJQR-UHFFFAOYSA-N rose bengal A Natural products O1C(=O)C(C(=CC=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 STRXNPAVPKGJQR-UHFFFAOYSA-N 0.000 claims description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims description 2
- 239000000975 dye Substances 0.000 claims description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 2
- 229910021389 graphene Inorganic materials 0.000 claims description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 2
- CUXQLKLUPGTTKL-UHFFFAOYSA-M microcosmic salt Chemical compound [NH4+].[Na+].OP([O-])([O-])=O CUXQLKLUPGTTKL-UHFFFAOYSA-M 0.000 claims description 2
- 239000000376 reactant Substances 0.000 claims description 2
- 125000001452 riboflavin group Chemical group 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 239000005977 Ethylene Substances 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 150000001336 alkenes Chemical class 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 claims 1
- XXQBGBUZLWZPKT-UHFFFAOYSA-N n-prop-2-enoylbuta-2,3-dienamide Chemical compound C=CC(=O)NC(=O)C=C=C XXQBGBUZLWZPKT-UHFFFAOYSA-N 0.000 claims 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 claims 1
- 239000003999 initiator Substances 0.000 abstract description 12
- 150000003254 radicals Chemical class 0.000 abstract description 10
- 238000006116 polymerization reaction Methods 0.000 abstract description 9
- 238000001723 curing Methods 0.000 abstract description 5
- 239000007864 aqueous solution Substances 0.000 abstract description 2
- 108010022355 Fibroins Proteins 0.000 abstract 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical class I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000000379 polymerizing effect Effects 0.000 description 4
- 230000000975 bioactive effect Effects 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 238000010526 radical polymerization reaction Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- CMEWLCATCRTSGF-UHFFFAOYSA-N N,N-dimethyl-4-nitrosoaniline Chemical compound CN(C)C1=CC=C(N=O)C=C1 CMEWLCATCRTSGF-UHFFFAOYSA-N 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 239000012295 chemical reaction liquid Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 230000033116 oxidation-reduction process Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 230000008023 solidification Effects 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- ODINCKMPIJJUCX-UHFFFAOYSA-N Calcium oxide Chemical compound [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 206010061188 Haematotoxicity Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 206010029350 Neurotoxicity Diseases 0.000 description 1
- DMGNFLJBACZMRM-UHFFFAOYSA-N O[P] Chemical compound O[P] DMGNFLJBACZMRM-UHFFFAOYSA-N 0.000 description 1
- 206010044221 Toxic encephalopathy Diseases 0.000 description 1
- 238000003848 UV Light-Curing Methods 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000004964 aerogel Substances 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 125000002362 bornane-2,3-dione group Chemical group 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000010382 chemical cross-linking Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100000226 haematotoxicity Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229920001600 hydrophobic polymer Polymers 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000012690 ionic polymerization Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 231100000228 neurotoxicity Toxicity 0.000 description 1
- 230000007135 neurotoxicity Effects 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000037048 polymerization activity Effects 0.000 description 1
- ARGZBGBUZXUAHM-UHFFFAOYSA-L potassium sodium hydrogen sulfite sulfooxy sulfate Chemical compound [Na+].[K+].OS([O-])=O.OS(=O)(=O)OOS([O-])(=O)=O ARGZBGBUZXUAHM-UHFFFAOYSA-L 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000012966 redox initiator Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000759 toxicological effect Toxicity 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F2/00—Processes of polymerisation
- C08F2/46—Polymerisation initiated by wave energy or particle radiation
- C08F2/48—Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light
- C08F2/50—Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light with sensitising agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/52—Amides or imides
- C08F220/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
- C08F220/56—Acrylamide; Methacrylamide
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F299/00—Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers
- C08F299/02—Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers from unsaturated polycondensates
- C08F299/026—Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers from unsaturated polycondensates from the reaction products of polyepoxides and unsaturated monocarboxylic acids, their anhydrides, halogenides or esters with low molecular weight
- C08F299/028—Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers from unsaturated polycondensates from the reaction products of polyepoxides and unsaturated monocarboxylic acids, their anhydrides, halogenides or esters with low molecular weight photopolymerisable compositions
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2333/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
- C08J2333/24—Homopolymers or copolymers of amides or imides
- C08J2333/26—Homopolymers or copolymers of acrylamide or methacrylamide
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2353/00—Characterised by the use of block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives of such polymers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Dispersion Chemistry (AREA)
- Transplantation (AREA)
- Materials Engineering (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials For Medical Uses (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Polymerisation Methods In General (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610705826.7A CN106317263B (zh) | 2016-08-23 | 2016-08-23 | 一种医用光固化水凝胶中可见光引发体系及其光固化方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610705826.7A CN106317263B (zh) | 2016-08-23 | 2016-08-23 | 一种医用光固化水凝胶中可见光引发体系及其光固化方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106317263A true CN106317263A (zh) | 2017-01-11 |
CN106317263B CN106317263B (zh) | 2017-12-22 |
Family
ID=57741580
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610705826.7A Active CN106317263B (zh) | 2016-08-23 | 2016-08-23 | 一种医用光固化水凝胶中可见光引发体系及其光固化方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106317263B (zh) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107028639A (zh) * | 2017-05-19 | 2017-08-11 | 北京泰杰伟业科技有限公司 | 一种血流导向装置的输送器和血流导向装置 |
CN107469139A (zh) * | 2017-07-31 | 2017-12-15 | 河南工程学院 | 一种兼具有抗菌和消炎效果的高强度创伤敷料的制备方法 |
CN107469140A (zh) * | 2017-08-14 | 2017-12-15 | 高鼎精细化工(昆山)有限公司 | 一种具抗菌功能的光动力学抗菌敷料、制备方法及应用 |
CN107619824A (zh) * | 2017-10-30 | 2018-01-23 | 北京化工大学 | 一种基于光固化水凝胶制备固定化酶方法 |
CN107744601A (zh) * | 2017-09-06 | 2018-03-02 | 盐城工业职业技术学院 | 一种基于蚕丝微球生物墨水的三维打印伤口包覆材料及其制备方法 |
CN107936158A (zh) * | 2017-12-22 | 2018-04-20 | 中科院广州化学有限公司 | 一种光引发的高分子聚合物及其制备方法 |
CN108467464A (zh) * | 2018-04-02 | 2018-08-31 | 常熟理工学院 | 含壬二酸可见光固化水凝胶及其制备方法 |
CN109111555A (zh) * | 2018-07-18 | 2019-01-01 | 海南师范大学 | 一种高效生物相容性自由基光聚合可见光引发体系的制备方法 |
CN109674770A (zh) * | 2019-02-18 | 2019-04-26 | 上海交通大学 | 一种可控制多肽类药物释放的控释膜及其制备方法与应用 |
CN109942752A (zh) * | 2019-03-22 | 2019-06-28 | 华南农业大学 | 改性羧甲基纤维素生物相容性复合水凝胶前驱液、复合水凝胶及其应用 |
CN111072796A (zh) * | 2019-12-30 | 2020-04-28 | 北京化工大学 | 一种吡咯基酮光引发体系及应用 |
CN112934146A (zh) * | 2021-02-09 | 2021-06-11 | 江南大学 | 一种光驱动光催化反应器及其制备方法 |
CN114177356A (zh) * | 2021-12-13 | 2022-03-15 | 中国药科大学 | 一种可用于光固化3d打印的打印墨水的制备方法及其应用 |
CN114230678A (zh) * | 2021-12-13 | 2022-03-25 | 珠海通桥医疗科技有限公司 | 一种用于血管内治疗的光交联水凝胶栓塞***及使用方法 |
CN114907502A (zh) * | 2022-05-18 | 2022-08-16 | 中国科学院理化技术研究所 | 一种可见光引发剂体系及其应用 |
CN116078440A (zh) * | 2023-01-17 | 2023-05-09 | 中山大学 | 一种高效吸附降解苯甲醛的多孔光催化凝胶及其制备方法和应用 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1158854A (zh) * | 1995-11-24 | 1997-09-10 | 希巴特殊化学控股公司 | 用于光聚合的硼酸盐助引发剂 |
CN1545643A (zh) * | 2001-08-21 | 2004-11-10 | �������⻯ѧƷ�ع�����˾ | 红移单-和双-酰基氧化膦和硫化膦及其作为光引发剂的应用 |
CN1703434A (zh) * | 2002-10-02 | 2005-11-30 | 科洛普拉斯特公司 | 水凝胶 |
CN103044703A (zh) * | 2013-01-17 | 2013-04-17 | 古元安 | 多孔水凝胶和无孔水凝胶制备工艺 |
WO2014123761A1 (en) * | 2013-02-06 | 2014-08-14 | Virginia Commonwealth University | Photoactive silk protein and fabrication of silk protein structures using photolithography |
CN105177988A (zh) * | 2015-10-10 | 2015-12-23 | 浙江理工大学 | 一种用于纺织品数码功能整理的蓝光固化自由基/阳离子混杂体系 |
CN105218708A (zh) * | 2015-10-13 | 2016-01-06 | 浙江理工大学 | 一种引发自由基、阳离子聚合的可见光引发体系 |
-
2016
- 2016-08-23 CN CN201610705826.7A patent/CN106317263B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1158854A (zh) * | 1995-11-24 | 1997-09-10 | 希巴特殊化学控股公司 | 用于光聚合的硼酸盐助引发剂 |
CN1545643A (zh) * | 2001-08-21 | 2004-11-10 | �������⻯ѧƷ�ع�����˾ | 红移单-和双-酰基氧化膦和硫化膦及其作为光引发剂的应用 |
CN1703434A (zh) * | 2002-10-02 | 2005-11-30 | 科洛普拉斯特公司 | 水凝胶 |
CN103044703A (zh) * | 2013-01-17 | 2013-04-17 | 古元安 | 多孔水凝胶和无孔水凝胶制备工艺 |
WO2014123761A1 (en) * | 2013-02-06 | 2014-08-14 | Virginia Commonwealth University | Photoactive silk protein and fabrication of silk protein structures using photolithography |
CN105177988A (zh) * | 2015-10-10 | 2015-12-23 | 浙江理工大学 | 一种用于纺织品数码功能整理的蓝光固化自由基/阳离子混杂体系 |
CN105218708A (zh) * | 2015-10-13 | 2016-01-06 | 浙江理工大学 | 一种引发自由基、阳离子聚合的可见光引发体系 |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107028639A (zh) * | 2017-05-19 | 2017-08-11 | 北京泰杰伟业科技有限公司 | 一种血流导向装置的输送器和血流导向装置 |
CN107469139A (zh) * | 2017-07-31 | 2017-12-15 | 河南工程学院 | 一种兼具有抗菌和消炎效果的高强度创伤敷料的制备方法 |
CN107469140A (zh) * | 2017-08-14 | 2017-12-15 | 高鼎精细化工(昆山)有限公司 | 一种具抗菌功能的光动力学抗菌敷料、制备方法及应用 |
CN107469140B (zh) * | 2017-08-14 | 2021-01-05 | 高鼎精细化工(昆山)有限公司 | 一种具抗菌功能的光动力学抗菌敷料、制备方法及应用 |
CN107744601A (zh) * | 2017-09-06 | 2018-03-02 | 盐城工业职业技术学院 | 一种基于蚕丝微球生物墨水的三维打印伤口包覆材料及其制备方法 |
CN107744601B (zh) * | 2017-09-06 | 2020-09-25 | 盐城工业职业技术学院 | 一种基于蚕丝微球生物墨水的三维打印伤口包覆材料及其制备方法 |
CN107619824A (zh) * | 2017-10-30 | 2018-01-23 | 北京化工大学 | 一种基于光固化水凝胶制备固定化酶方法 |
CN107936158A (zh) * | 2017-12-22 | 2018-04-20 | 中科院广州化学有限公司 | 一种光引发的高分子聚合物及其制备方法 |
CN108467464A (zh) * | 2018-04-02 | 2018-08-31 | 常熟理工学院 | 含壬二酸可见光固化水凝胶及其制备方法 |
CN109111555B (zh) * | 2018-07-18 | 2020-09-04 | 海南师范大学 | 一种高效生物相容性自由基光聚合可见光引发体系的制备方法 |
CN109111555A (zh) * | 2018-07-18 | 2019-01-01 | 海南师范大学 | 一种高效生物相容性自由基光聚合可见光引发体系的制备方法 |
CN109674770A (zh) * | 2019-02-18 | 2019-04-26 | 上海交通大学 | 一种可控制多肽类药物释放的控释膜及其制备方法与应用 |
CN109942752A (zh) * | 2019-03-22 | 2019-06-28 | 华南农业大学 | 改性羧甲基纤维素生物相容性复合水凝胶前驱液、复合水凝胶及其应用 |
CN111072796A (zh) * | 2019-12-30 | 2020-04-28 | 北京化工大学 | 一种吡咯基酮光引发体系及应用 |
CN111072796B (zh) * | 2019-12-30 | 2021-05-11 | 北京化工大学 | 一种吡咯基酮光引发体系及应用 |
CN112934146A (zh) * | 2021-02-09 | 2021-06-11 | 江南大学 | 一种光驱动光催化反应器及其制备方法 |
CN114177356A (zh) * | 2021-12-13 | 2022-03-15 | 中国药科大学 | 一种可用于光固化3d打印的打印墨水的制备方法及其应用 |
CN114230678A (zh) * | 2021-12-13 | 2022-03-25 | 珠海通桥医疗科技有限公司 | 一种用于血管内治疗的光交联水凝胶栓塞***及使用方法 |
CN114230678B (zh) * | 2021-12-13 | 2023-09-01 | 珠海通桥医疗科技有限公司 | 一种用于血管内治疗的光交联水凝胶栓塞***及使用方法 |
CN114907502A (zh) * | 2022-05-18 | 2022-08-16 | 中国科学院理化技术研究所 | 一种可见光引发剂体系及其应用 |
CN114907502B (zh) * | 2022-05-18 | 2024-02-06 | 中国科学院理化技术研究所 | 一种可见光引发剂体系及其应用 |
CN116078440A (zh) * | 2023-01-17 | 2023-05-09 | 中山大学 | 一种高效吸附降解苯甲醛的多孔光催化凝胶及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN106317263B (zh) | 2017-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106317263B (zh) | 一种医用光固化水凝胶中可见光引发体系及其光固化方法 | |
Korde et al. | Naturally biomimicked smart shape memory hydrogels for biomedical functions | |
Bao et al. | Challenges and opportunities in 3D printing of biodegradable medical devices by emerging photopolymerization techniques | |
Ashfaq et al. | Polymerization reactions and modifications of polymers by ionizing radiation | |
Pellá et al. | Chitosan-based hydrogels: From preparation to biomedical applications | |
Truong et al. | Wavelength-selective coupling and decoupling of polymer chains via reversible [2+ 2] photocycloaddition of styrylpyrene for construction of cytocompatible photodynamic hydrogels | |
Xu et al. | Highly elastic biodegradable single-network hydrogel for cell printing | |
Baroli | Photopolymerization of biomaterials: issues and potentialities in drug delivery, tissue engineering, and cell encapsulation applications | |
CN101670095B (zh) | 一种用于栓塞治疗的药物组合物及其制备方法 | |
EP3774338B1 (en) | Methods and compositions for photopolymerizable additive manufacturing | |
CN109942752B (zh) | 改性羧甲基纤维素生物相容性复合水凝胶前驱液、复合水凝胶及其应用 | |
Maiz-Fernández et al. | Polysaccharide-based in situ self-healing hydrogels for tissue engineering applications | |
Wang et al. | Recent advances in host‐guest supramolecular hydrogels for biomedical applications | |
CN103910894A (zh) | 一种可注射的天然多糖自愈合水凝胶的制备方法 | |
Bi et al. | In situ-forming cross-linking hydrogel systems: chemistry and biomedical applications | |
US10548919B2 (en) | Shear-thinning hydrogel, kit and method of preparation | |
Wu et al. | Novel digital light processing printing strategy using a collagen-based bioink with prospective cross-linker procyanidins | |
Cai et al. | Application of polymer hydrogels in the prevention of postoperative adhesion: A review | |
Dodda et al. | Crosslinking trends in multicomponent hydrogels for biomedical applications | |
CN107715175A (zh) | 一种plga/两性离子复合多孔骨组织工程支架及其制备方法 | |
Jongprasitkul et al. | Sequential cross-linking of gallic acid-functionalized GelMA-based bioinks with enhanced printability for extrusion-based 3D bioprinting | |
CN109111555A (zh) | 一种高效生物相容性自由基光聚合可见光引发体系的制备方法 | |
Lee et al. | Green chemistry for crosslinking biopolymers: Recent advances in riboflavin-mediated photochemistry | |
Tan et al. | Photo-crosslinkable hydrogels for 3d bioprinting in the repair of osteochondral defects: A review of present applications and future perspectives | |
del Olmo et al. | Sustained drug release from biopolymer-based hydrogels and hydrogel coatings |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201120 Address after: No. 54, group 6, Qianjin village, Baima Town, Gaogang District, Taizhou City, Jiangsu Province Patentee after: Wang Yajun Address before: 310018 room 2, building 18, Xiasha campus, Xiasha Higher Education Zone, Hangzhou, Zhejiang, Patentee before: Zhejiang University of Technology |
|
TR01 | Transfer of patent right |
Effective date of registration: 20210204 Address after: 225300 No.25 Chunhui Road, Zhangguo Town, Xinghua City, Taizhou City, Jiangsu Province Patentee after: Xinghua Lingyi science and Technology Consulting Service Co., Ltd Address before: No. 54, group 6, Qianjin village, Baima Town, Gaogang District, Taizhou City, Jiangsu Province Patentee before: Wang Yajun |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211101 Address after: 750000 group 3, Hongxi village, Hongguang Town, Helan County, Yinchuan City, Ningxia Hui Autonomous Region Patentee after: He Cong Address before: 225300 No.25 Chunhui Road, Zhangguo Town, Xinghua City, Taizhou City, Jiangsu Province Patentee before: Xinghua Lingyi science and Technology Consulting Service Co., Ltd |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211110 Address after: 730000 No. 11 Gucheng Ping, Chengguan District, Lanzhou City, Gansu Province Patentee after: Gansu Jindun Chemical Co., Ltd Address before: 750000 group 3, Hongxi village, Hongguang Town, Helan County, Yinchuan City, Ningxia Hui Autonomous Region Patentee before: He Cong |
|
TR01 | Transfer of patent right |